Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine + ropivacaine epidural analgesia and maternal intrapartum/postpartum fever
ChiCTR2500104424Phase 4Not yet recruiting
- Sponsor
- Affiliated Women and Children's Hospital of Ningbo University
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of lidocaine and ropivacaine (3 arms), sponsored by Affiliated Women and Children's Hospital of Ningbo University. Primary endpoint: Incidence of epidural-related maternal fever (ERMF). Planned start Jun 2025; status: not yet recruiting.
02
Drugs
lidocaineropivacaine
Beyond the preview
Go deeper on ChiCTR2500104424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104424.